Dara signs agreement with WellCare for Soltamox formulary status

theflyonthewall.com

DARA BioSciences announced that the company signed a Medicare Part D Prescription Drug Program Reimbursement Agreement with Comprehensive Health Management, providing formulary status for the WellCare Group of companies for Soltamox oral solution. DARA holds exclusive U.S. marketing rights to Soltamox.

View Comments (0)